This brand name is authorized in Estonia, Lithuania, Poland
The drug LINGABAT contains one active pharmaceutical ingredient (API):
1
Pregabalin
UNII 55JG375S6M - PREGABALIN
|
Pregabalin binds to an auxiliary subunit (α2-δ protein) of voltage-gated calcium channels in the central nervous system. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
N02BF02 | Pregabalin | N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BF Gabapentinoids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: EE | Ravimiamet | Identifier(s): 1656097, 1656109, 1656121, 1656132, 1695214 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1073893, 1073894, 1076344, 1078785, 1078786 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100380761, 100380778, 100380790, 100380809 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.